AR108591A1 - Composición acuosa que contiene atropina - Google Patents

Composición acuosa que contiene atropina

Info

Publication number
AR108591A1
AR108591A1 ARP170101418A ARP170101418A AR108591A1 AR 108591 A1 AR108591 A1 AR 108591A1 AR P170101418 A ARP170101418 A AR P170101418A AR P170101418 A ARP170101418 A AR P170101418A AR 108591 A1 AR108591 A1 AR 108591A1
Authority
AR
Argentina
Prior art keywords
buffer
aqueous composition
composition according
atropina
composition containing
Prior art date
Application number
ARP170101418A
Other languages
English (en)
Spanish (es)
Inventor
Toyomi Fujisawa
Takashi Morimoto
Koji Sakanaka
Kyohei Takahashi
Hiroyuki Asada
Roger Beuerman
Donald Tan
Original Assignee
Singapore Health Serv Pte Ltd
Univ Nanyang Tech
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60411416&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR108591(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Singapore Health Serv Pte Ltd, Univ Nanyang Tech, Santen Pharmaceutical Co Ltd filed Critical Singapore Health Serv Pte Ltd
Publication of AR108591A1 publication Critical patent/AR108591A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/08—Mydriatics or cycloplegics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Materials For Photolithography (AREA)
ARP170101418A 2016-05-25 2017-05-24 Composición acuosa que contiene atropina AR108591A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG10201604200P 2016-05-25

Publications (1)

Publication Number Publication Date
AR108591A1 true AR108591A1 (es) 2018-09-05

Family

ID=60411416

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170101418A AR108591A1 (es) 2016-05-25 2017-05-24 Composición acuosa que contiene atropina

Country Status (15)

Country Link
US (2) US20210267885A1 (OSRAM)
EP (2) EP4112055A1 (OSRAM)
JP (6) JP6590860B2 (OSRAM)
KR (4) KR102580933B1 (OSRAM)
CN (3) CN109310687B (OSRAM)
AR (1) AR108591A1 (OSRAM)
CA (1) CA3023149C (OSRAM)
EA (1) EA201892703A1 (OSRAM)
ES (1) ES2929368T3 (OSRAM)
MY (1) MY189774A (OSRAM)
PH (1) PH12018502421A1 (OSRAM)
SG (1) SG11201809822SA (OSRAM)
TW (3) TWI791438B (OSRAM)
UA (1) UA126195C2 (OSRAM)
WO (1) WO2017204262A1 (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016172712A2 (en) * 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
WO2016196367A1 (en) 2015-05-29 2016-12-08 Sydnexis, Inc. D2o stabilized pharmaceutical formulations
AU2018224426B2 (en) * 2017-02-21 2023-05-18 Singapore Health Services Pte Ltd Composition and method for preventing or delaying onset of myopia comprising atropine
ES2901140T3 (es) 2017-05-11 2022-03-21 Vyluma Inc Composiciones farmacéuticas de atropina
CN109157503B (zh) * 2018-09-25 2019-08-16 沈阳兴齐眼药股份有限公司 防治nitm的药物组合物及其医药用途
CN114557955B (zh) 2018-09-25 2024-06-18 沈阳兴齐眼药股份有限公司 药物组合物、其制备方法和用途
PT3701938T (pt) 2019-03-01 2024-01-31 Medivis S R L Formulações oftálmicas à base de atropina
BR112023001720A2 (pt) * 2020-08-04 2023-03-28 Santen Pharmaceutical Co Ltd Composição farmacêutica para o tratamento da miopia, prevenção da miopia e/ou supressão da progressão da miopia, para suprimir o alongamento do comprimento axial e para suprimir o erro de refração, e, uso de (+)-11-[2-[2-[(dietilamino)metil]-1-piperidinil]acetil]-5,11-di-hidro-6h-pirido[2,3-b][1,4]benzodiazepina-6-ona ou um sal da mesma
MX2023004276A (es) * 2020-10-14 2023-05-02 Santen Pharmaceutical Co Ltd Composicion farmaceutica estable.
AU2021368138A1 (en) 2020-11-02 2023-06-22 Trethera Corporation Crystalline forms of a deoxycytidine kinase inhibitor and uses thereof
WO2022130337A1 (en) * 2020-12-17 2022-06-23 Sun Pharmaceutical Industries Limited An aqueous sterile solution of atropine for ophthalmic use
EP4088714A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
EP4088713A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
US20230120997A1 (en) * 2021-10-18 2023-04-20 Ocular Science, Inc. Compositions and methods for myopia control and orthokeratology lenses treatment
CN114129511A (zh) * 2021-12-07 2022-03-04 河南润弘制药股份有限公司 一种具有改进稳定性的硫酸阿托品注射液
AU2023337098A1 (en) * 2022-09-11 2024-10-03 Alcon Inc. Aqueous pharmaceutical compositions comprising benzyl atropine and uses thereof
JP7665073B1 (ja) 2024-04-05 2025-04-18 ロート製薬株式会社 容器に収容してなる眼科用組成物
JP7723851B1 (ja) * 2024-11-22 2025-08-14 参天製薬株式会社 アトロピン含有水性医薬組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617508B2 (ja) * 1988-02-05 1997-06-04 エーザイ株式会社 安定なジフェンヒドラミン含有水溶液
JP3166002B2 (ja) * 1997-01-27 2001-05-14 日本車輌製造株式会社 自動車の洗浄装置
US20030096831A1 (en) 2000-01-18 2003-05-22 Stone Richard A. Ocular growth and nicotinic antagonists
MXPA03010655A (es) * 2001-05-25 2007-06-22 Valley Forge Pharmaceuticals I Gel oft??lmico de pirenzepina.
US20070254914A1 (en) * 2006-05-01 2007-11-01 Non-Profit Organization Chang Gung Memorial Hospital Low-concentration atropine solution for preventing myopia progression and preparing method thereof
JP2007308398A (ja) * 2006-05-17 2007-11-29 Chang Gung Memorial Hospital 目薬、及びその製造方法
CA2688811A1 (en) * 2007-05-21 2008-11-27 Neuroptix Corporation Ophthalmic formulations of amyloid-beta contrast agents and methods of use thereof
CN101327216A (zh) * 2007-06-22 2008-12-24 肖正连 一种硫酸阿托品眼用即型凝胶
WO2012161655A1 (en) * 2011-05-23 2012-11-29 Singapore Health Services Pte Ltd Composition and/or method for reducing and/or preventing myopia progression comprising atropine
US20160009705A1 (en) * 2014-06-24 2016-01-14 Sydnexis, Inc. Ophthalmic composition
US9421199B2 (en) * 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
JP2017102939A (ja) * 2016-12-26 2017-06-08 株式会社プロフィールド オーサリング装置、オーサリング方法、およびプログラム
ES2901140T3 (es) * 2017-05-11 2022-03-21 Vyluma Inc Composiciones farmacéuticas de atropina

Also Published As

Publication number Publication date
EP3463360A1 (en) 2019-04-10
KR102580933B1 (ko) 2023-09-19
JP2023058574A (ja) 2023-04-25
TW202325296A (zh) 2023-07-01
TW201808289A (zh) 2018-03-16
JP7224390B2 (ja) 2023-02-17
CN117205210A (zh) 2023-12-12
JP2020007356A (ja) 2020-01-16
JP6886502B2 (ja) 2021-06-16
JP6590860B2 (ja) 2019-10-16
MY189774A (en) 2022-03-04
US20240307305A1 (en) 2024-09-19
KR20230141882A (ko) 2023-10-10
TWI849355B (zh) 2024-07-21
WO2017204262A1 (en) 2017-11-30
PH12018502421A1 (en) 2019-09-30
CN117205209A (zh) 2023-12-12
TWI874894B (zh) 2025-03-01
KR20250067951A (ko) 2025-05-15
TWI791438B (zh) 2023-02-11
JP2025084921A (ja) 2025-06-03
SG11201809822SA (en) 2018-12-28
CA3023149A1 (en) 2017-11-30
CA3023149C (en) 2024-07-02
JP2018021007A (ja) 2018-02-08
EP3463360A4 (en) 2020-01-29
JP2025176149A (ja) 2025-12-03
KR102804061B1 (ko) 2025-05-07
US20210267885A1 (en) 2021-09-02
UA126195C2 (uk) 2022-08-31
CN109310687A (zh) 2019-02-05
TW202206070A (zh) 2022-02-16
CN109310687B (zh) 2023-10-20
KR20220154842A (ko) 2022-11-22
JP2021120404A (ja) 2021-08-19
KR20190013877A (ko) 2019-02-11
ES2929368T3 (es) 2022-11-28
EP3463360B1 (en) 2022-08-31
EP4112055A1 (en) 2023-01-04
EA201892703A1 (ru) 2019-04-30

Similar Documents

Publication Publication Date Title
AR108591A1 (es) Composición acuosa que contiene atropina
BR112017003302A2 (pt) sal de adição de ácido do composto inibidor de trk
AR074541A1 (es) Composiciones desinfectantes de plata naturales
JP2018021007A5 (OSRAM)
MX352949B (es) Composicion farmaceutica.
AR105044A1 (es) Soluciones de esteroides neuroactivos y sus métodos de uso, recipiente
AR105199A1 (es) Soluciones oftálmicas acuosas
BR112018074352A2 (pt) partículas de nanoalume contendo um agente de dimensionamento
BR112016024454A2 (pt) solução oftálmica aquosa e método para o tratamento da síndrome do olho seco
MX2020011849A (es) Detergente enzimático de multiples usos y métodos de estabilizar una solución de uso.
BR112015026685A2 (pt) agente de diminuição de ácido úrico
HRP20220793T1 (hr) Oftalmološki vodeni sastav
EA201690079A1 (ru) Композиция, содержащая глутаминовую-n,n-диуксусную кислоту (glda), воду и фермент
AR099201A1 (es) Composiciones de limpieza que contienen plata estable
MX2013007502A (es) Solucion oftalmica que comprende diquafosol, metodo para producir la misma, y metodo para inhibir la formacion de precipitado insoluble.
AR087371A1 (es) Formulaciones de (trimetoxifenilamino)pirimidinilo, metodos
MX2016006651A (es) Soluciones para incrementar la estabilidad y la vida util de una solucion de conservacion de organos y tejidos.
MX373027B (es) Barra de jabon que tiene actividad antibacteriana mejorada.
MX345216B (es) Solucion oftalmica que contiene acido hialuronico o sal del mismo y propilenglicol.
CL2017001039A1 (es) Composiciones anti-transpirantes anhidras
AR089831A1 (es) Una composicion y un metodo para tratar sustratos
MX376456B (es) Composición acuosa con contenido de metal oligodinámico.
AR098999A1 (es) Proceso de disolución o extracción de al menos un metal precioso de un material fuente que lo contiene y composición utilizada
MY199389A (en) Methods of preserving the biological activity or ribonucleic acids
GR20140100657A (el) Οξινο κιτρικο διαλυμα αιμοκαθαρσης

Legal Events

Date Code Title Description
FC Refusal